Solution to One Prop. 71 Flaw
By Jesse Reynolds,
Los Angeles Times
| 12. 17. 2007
A Letter to the Editor
Re "Stem cell housecleaning," editorial, Dec. 12
Your editorial appropriately highlights fundamental flaws of Proposition 71, the initiative that created the state's $3-billion stem cell research agency. Its governing board is stacked with representatives of the very institutions seeking to maximize their share of the public funding pie -- an inherent conflict of interest. The latest scandal, in which a board member tried to influence a grant to his home institution, is just a symptom of the structural flaws that were built into the program. It's time for the Legislature to step in and reform it.
But that's just part of the problem. Board chair and Proposition 71 author Robert Klein has consistently worked against accountability and transparency. He has misled the public and has been dismissive of the Legislature. Through activities such as heading up his own private stem cell research lobbying group while continuing his role as board chair, he's crossed the line of appropriate behavior for a public servant. He's had three years to demonstrate otherwise. It's time for him to go.
Jesse Reynolds
Oakland
The writer...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...